维普期刊资源整合服务平台（V6.5）

365篇 您的检索式：作者名="BURNETT JC"

选中清除导出查看参考文献查看引证文献引用追踪共19页首页上一页第1页下一页末页 /19 跳转

	题名	作者	年代	出处	被引量
1	The natriuretic peptides in cardiovascular medicine显示文摘	Munagala VK Burnett JC Redfield MM	2004	Curr Probl cardiol2004，29，12：	2
2	Natriuretic peptides and remodeling in heart failure 显示文摘	Burnett JC	2005	Heart Fail Clin2005，1，1：	1
3	Ca- rotidartery atheroma: comparison of preoperative B-mode ul-tra- sound appearance with carotid endarterectomy speci-men pa- thology显示文摘	ray-Weale AC Graham JC Burnett JR	1988	Cardiovasc Surg1988，29，6：	1
4	Stochastic gene expression in a lentiviral positive-feedbackloop: HIV-1 Tat fluctuations drive phenotypic diversity 显示文摘	Weinberger LS Burnett JC Toettcher JE Arkin AA	2005	Cell2005，122，2：	1
5	Alternate cir-culating pro-B-type natriuretic peptide and B-type natriureticpeptide forms in the general population显示文摘	Lam CS Burnett JC Jr Costello-Boerrigter L	2007	J Am Coll Cardiol2007，49，11：	1
6	Adrenomedullin: potential in physiology and pathophysiology显示文摘	Jougasaki M Burnett JC	2000	Life Sci2000，66，10：	1
7	Novel therapeutic directions for the natriuretic peptides in cardiovascular diseases : what7 s on the horizon显示文摘	Burnett JC	2006	J Cardiol2006，48，5：	1
8	Novel therapeutic directions for the natriuretie peptides in cardiovascular diseases : what' s on the horizon 显示文摘	Burnett JC Jr	2006	J cardiol2006，48，5：	1
9	The prognostic value of N-terminal proB-type natriuretic peptide显示文摘	Costello-Boerrigter LC Burnett JC	2005	Nat Clin Pract Cardiovasc Med2005，2，2：	1
10	Matrix metalloproteinases : pathways of induction by bio- active molecules显示文摘	Tsuruda T Costello - Boerrigter LC Burnett JC Jr	2004	Heart Fail Rev2004，9，1：	1
11	Short term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials显示文摘	Gheorghiade M Konstam MA Burnett JC Jr	2007	JAMA2007，297，12：	1
12	Short term clinical effects of tolvaptan,an oral vasopressin antagonist,in patients hospitalized for heart failure: results of the EVEREST clinical status trials显示文摘	Gheorghiade M Konstam MA Burnett JC	2007	JAMA2007，297，12：	1
13	Effects of oral tolvaptan in patients hospitalized for worsening heart {ailure: the EVEREST Outcome Trial显示文摘	Gheorghiade M Konstam MA Burnett JC Jr	2007	JAMA2007，297，12：	1
14	The association between daily mortality and ambient air particle pollution in Montreal, Quebec 显示文摘	Goldberg MS Burnett RT Bailar JC	2001	Environ Res2001，86，1：	1
15	Differential sensitivity to endothelin oncanine arteries and veins显示文摘	Miller VM Komori K Burnett JC	1989	Am J Physiol1989，257，6：	1
16	Natriuretic peptide levels in atrial fibrillation:a prospective hormonal and doppler-echocardiographic study显示文摘	Rossi A Enriquez SM Burnett JC Jr	2000	J Am Coll Cardiol2000，35，5：	1
17	Natriuretic peptides in the pathophysiology of congestive heart failure显示文摘	Chen HH Burnett JC		0，，03：	1
18	Nesiritide : new hope for acute heart failure syndromes 显示文摘	Burnett JC	2005	Eur Heart J2005，7，：	1
19	RNA-based therapeutics: current progress and future prospects显示文摘	Burnett JC Rossi JJ	2012	Chem Biol2012，19，1：	1
20	Natriuretic peptides and remodeling in heart failure显示文摘	Burnett JC	2005	Heart Fail Clin2005，1，1：	1

返回顶部每页显示：

共19页首页上一页第1页下一页末页 /19 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示